2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRISTOL, LYNN ANNE | 1 | 63.5% | +39.8% |
| NATARAJAN, MEERA | 1 | 62.5% | +17.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18495468 | ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF | BRISTOL, LYNN ANNE | — |
| 18476108 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF | NATARAJAN, MEERA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18495468 | ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF | BRISTOL, LYNN ANNE | — | DP | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18476108 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF | NATARAJAN, MEERA | — | DP | Non-Final OA | — | Pending | Sep 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial